Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Urate-lowering therapy following a treat-to-target continuation strategy compared to a treat-to-avoid-symptoms discontinuation strategy in gout patients in remission (GO TEST Finale): study protocol of a multicentre pragmatic randomized superiority trial.
Peeters IR, den Broeder AA, Taylor WJ, den Broeder N, Flendrie M, van Herwaarden N. Peeters IR, et al. Among authors: den broeder n, den broeder aa. Trials. 2023 Apr 19;24(1):282. doi: 10.1186/s13063-023-07242-y. Trials. 2023. PMID: 37072799 Free PMC article.
Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis.
Tweehuysen L, den Broeder N, van Herwaarden N, Joosten LAB, van Lent PL, Vogl T, van den Hoogen FHJ, Thurlings RM, den Broeder AA. Tweehuysen L, et al. Among authors: den broeder n, den broeder aa. RMD Open. 2018 Apr 9;4(1):e000654. doi: 10.1136/rmdopen-2018-000654. eCollection 2018. RMD Open. 2018. PMID: 29657832 Free PMC article.
Three-year cost-effectiveness analysis of the DRESS study: protocolised tapering is key.
den Broeder N, Bouman CAM, Kievit W, van Herwaarden N, van den Hoogen FHJ, van Vollenhoven RF, Bijlsma HWJ, van der Maas A, den Broeder AA. den Broeder N, et al. Among authors: den broeder aa. Ann Rheum Dis. 2019 Jan;78(1):141-142. doi: 10.1136/annrheumdis-2018-213547. Epub 2018 Aug 27. Ann Rheum Dis. 2019. PMID: 30150367 No abstract available.
Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial.
Michielsens CAJ, Boers N, den Broeder N, Wenink MH, van der Maas A, Mahler EAM, Mulder MLM, van der Heijde D, van den Hoogen FHJ, Verhoef LM, den Broeder AA. Michielsens CAJ, et al. Among authors: den broeder n, den broeder aa. Trials. 2020 Jan 15;21(1):90. doi: 10.1186/s13063-019-4000-5. Trials. 2020. PMID: 31941544 Free PMC article. Clinical Trial.
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA).
Mulder MLM, Vriezekolk JE, den Broeder N, Mahler EAM, Helliwell PS, van den Hoogen FHJ, den Broeder AA, Wenink MH. Mulder MLM, et al. Among authors: den broeder n, den broeder aa. Trials. 2020 Feb 10;21(1):155. doi: 10.1186/s13063-020-4097-6. Trials. 2020. PMID: 32041657 Free PMC article.
45 results